Traders bought shares of Monsanto Co. (NYSE:MON) on weakness during trading hours on Friday following insider selling activity. $135.47 million flowed into the stock on the tick-up and $53.93 million flowed out of the stock on the tick-down, for a money net flow of $81.54 million into the stock. Of all companies tracked, Monsanto had the highest net in-flow for the day. Monsanto traded down ($0.43) for the day and closed at $102.11Specifically, EVP Steven Mizell sold 310 shares of the stock in a transaction dated Monday, October 10th. The shares were sold at an average price of $103.09, for a total transaction of $31,957.90. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Robert T. Fraley sold 80,631 shares of the stock in a transaction dated Friday, October 14th. The stock was sold at an average price of $102.04, for a total transaction of $8,227,587.24. Following the sale, the executive vice president now owns 38,711 shares in the company, valued at $3,950,070.44. The disclosure for this sale can be found here. Company insiders own 0.88% of the company’s stock.
A number of equities research analysts have issued reports on MON shares. Vetr downgraded shares of Monsanto from a “strong-buy” rating to a “buy” rating and set a $116.47 price objective on the stock. in a research note on Thursday, July 14th. Credit Agricole SA restated a “buy” rating on shares of Monsanto in a research note on Saturday, July 2nd. Deutsche Bank AG restated a “buy” rating and issued a $118.00 price target on shares of Monsanto in a research note on Thursday, June 30th. Jefferies Group restated a “buy” rating on shares of Monsanto in a research note on Wednesday, June 29th. Finally, Monness Crespi & Hardt upgraded shares of Monsanto from a “neutral” rating to a “buy” rating and raised their price target for the company from $106.93 to $130.00 in a research note on Monday, August 8th. Three analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. Monsanto presently has an average rating of “Buy” and a consensus target price of $114.65.
The stock has a market cap of $44.69 billion, a PE ratio of 34.17 and a beta of 1.19. The stock has a 50-day moving average price of $104.39 and a 200-day moving average price of $101.78.
Monsanto (NYSE:MON) last announced its earnings results on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of ($0.02) by $0.09. The company earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The firm’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.19) earnings per share. On average, analysts anticipate that Monsanto Co. will post $4.89 earnings per share for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Investors of record on Friday, October 7th will be issued a dividend of $0.54 per share. The ex-dividend date of this dividend is Wednesday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.12%. Monsanto’s dividend payout ratio is presently 71.05%.
Several institutional investors have recently made changes to their positions in the stock. Mycio Wealth Partners LLC increased its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock worth $113,000 after buying an additional 12 shares in the last quarter. Moody National Bank Trust Division increased its position in Monsanto by 0.3% in the second quarter. Moody National Bank Trust Division now owns 4,883 shares of the company’s stock worth $505,000 after buying an additional 15 shares during the period. Quadrant Capital Group LLC increased its position in Monsanto by 0.9% in the second quarter. Quadrant Capital Group LLC now owns 1,858 shares of the company’s stock worth $184,000 after buying an additional 16 shares during the period. Advisor Partners LLC increased its position in Monsanto by 0.4% in the second quarter. Advisor Partners LLC now owns 6,238 shares of the company’s stock worth $645,000 after buying an additional 23 shares during the period. Finally, Trust Co. of Vermont increased its position in Monsanto by 0.6% in the second quarter. Trust Co. of Vermont now owns 4,932 shares of the company’s stock worth $510,000 after buying an additional 30 shares during the period. Institutional investors own 79.02% of the company’s stock.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.